PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis From a Brazilian Private Perspective
Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1394
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2012
Authors
Publisher
Elsevier BV